drugset
drugset / Trial / NCT03856827

A Study of IW-6463 in Healthy Volunteers

NCT03856827 ↗

Phase 1 Completed 110 enrolled Tisento Therapeutics
RandomizedSequentialTriple-blindOther

Summary

Stage 1: To assess the safety and tolerability of single-ascending-dose levels of IW-6463 tablets when administered orally to healthy subjects Stage 2: To assess the safety and tolerability of multiple-ascending-dose levels of IW-6463 tablets administered orally to healthy subjects Stage 3: To assess the safety and tolerability of a single dose of IW-6463 when administered to health subjects in fed vs fasted states and explore the effects of food on IW-6463 pharmacokinetics (PK)

Timeline

Start
2019-02-06
Primary completion
2019-10-22
Completion
2019-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject zagociguat Small molecule — Oral

Indications

No indication recorded.